Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound. Disclaimer

LimitlessLab
Search the library Wishlist Cart, items: 0
LL-37

Recovery & Healing

LL-37

Also known as Cathelicidin, CAMP; precursor hCAP18

Limited human evidenceNot approvedWADA prohibited

Price range: €78 through €125

Discussed for: Infections, wound healing.

FIG. 2 ยท Amino-acid sequence of LL-37 (37 residues)
  1. L
  2. L
  3. G
  4. D
  5. F
  6. F
  7. R
  8. K
  9. S
  10. K
  11. E
  12. K
  13. I
  14. G
  15. K
  16. E
  17. F
  18. K
  19. R
  20. I
  21. V
  22. Q
  23. R
  24. I
  25. K
  26. D
  27. F
  28. L
  29. R
  30. N
  31. L
  32. V
  33. P
  34. R
  35. T
  36. E
  37. S
  • Hydrophobic
  • Polar
  • Positive charge
  • Negative charge
  • Glycine / proline
Effect strengthHow hard it acts on the body4/10
Proof levelHow well that is shown in humans3/10
Risk levelHow much can go wrong5/10

Editorial 1 to 10 estimates from published research, not measured values. How to read these

Save to wishlist
Save to wishlist

01 / Identity

What it is

LL-37 is a natural human peptide (37 aa). Main reported uses: infections, wound healing. Current status: not approved anywhere. FDA flagged it as a compounding safety risk (2023).

Molecule type
Natural human peptide (37 aa)
How it is taken
Injection, topical
Other names
Cathelicidin, CAMP; precursor hCAP18

Route only. This library does not publish doses or protocols.

02 / Mechanism

How it is thought to work

Natural antimicrobial peptide that kills bacteria and modulates immunity

Mechanisms seen in cells or animals do not always happen the same way in people.

03 / Potential benefits

What people use it for

Infections, wound healing

Limited human evidence

Small or low-quality human data. Most of what is claimed comes from animals, cells or anecdotes.

Listed uses are what people use it for, not proven outcomes.

04 / Known risks

Side effects and risks

Injection-site reactions; can worsen autoimmune/skin inflammation

Risk level 5 of 10

Moderate risk score: real side effects are known, and long-term safety is not settled.

Unknown long-term effects count as a risk, not as a clean record.

05 / Regulatory

Regulatory status

Status
Not approved
Details
Not approved anywhere. FDA flagged it as a compounding safety risk (2023)
Sport (WADA)
Yes: S0 (unapproved substance)

Status reflects information up to mid-2026 and changes over time. Check current sources.

06 / Evidence quality

How good is the evidence?

Limited: small human wound studies

How we grade evidence

07 / Notes and sources

Notes and sources

  • In 2023 the FDA placed it on its list of bulk substances with significant safety concerns for compounding.
  • Products sold online as research peptides are unregulated. Tests of such products often find wrong amounts, impurities or a different compound.
  • Anyone using compounds like this regularly should have medical supervision and bloodwork (for example IGF-1, glucose and HbA1c, hormones, lipids).
  • Source: Peptide Reference Table, an editorial review of published research up to mid-2026. Scores are 1 to 10 editorial estimates, not measured values. Regulatory and WADA status change over time.

Educational information only. Not medical advice. Talk to a qualified healthcare professional before using any compound.

Related compounds